Sorrento Therapeutics Inc.’s Follow-on Equity Offering

Kramer Levin represented Cantor Fitzgerald & Co., as the Lead Book-Running Manager, in a shelf takedown for 23,625,084 shares of the common stock of Sorrento Therapeutics…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here